ROUND CELL LIPOSARCOMA
Clinical trials for ROUND CELL LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ROUND CELL LIPOSARCOMA trials appear
Sign up with your email to follow new studies for ROUND CELL LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to revive failing cancer fighters in rare sarcomas
Disease control Recruiting nowThis early-phase trial tests an immunotherapy drug called N-803 in up to 8 people with synovial sarcoma or myxoid/round cell liposarcoma whose cancer got worse after a prior cell therapy. N-803 is designed to boost the patient's own immune cells that survived the earlier treatmen…
Matched conditions: ROUND CELL LIPOSARCOMA
Phase: EARLY_PHASE1 • Sponsor: Seth Pollack • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug duo aims to halt rare cancer's growth
Disease control Recruiting nowThis study tests whether combining two drugs, mirdametinib and palbociclib, can safely slow or stop advanced liposarcoma (a rare soft-tissue cancer). About 54 adults with liposarcoma that has spread or cannot be removed will receive different doses to find the best one. The main …
Matched conditions: ROUND CELL LIPOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC